What data powers the Rallies AI report for XLO?

Rallies AI research for XLO combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.

Is XLO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for XLO. It does not provide personalized investment advice.

XLO (Xilio Therapeutics, Inc. Common Stock) Stock Analysis - AI Report

Xilio Therapeutics, Inc. Common Stock (XLO) is a publicly traded Healthcare sector company. As of May 21, 2026, XLO trades at $8.44 with a market cap of $48.76M and a P/E ratio of -1.97. XLO moved +1.83% today. Year to date, XLO is -10.87%; over the trailing twelve months it is -32.88%. Its 52-week range spans $6.47 to $23.80. Rallies surfaces XLO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on XLO?

Rallies AI research for XLO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

XLO Key Metrics

Key financial metrics for XLO
Metric	Value
Price	$8.44
Market Cap	$48.76M
P/E Ratio	-1.97
EPS	$-4.19
Dividend Yield	0.00%
52-Week High	$23.80
52-Week Low	$6.47
Volume	0
Avg Volume	0
Revenue (TTM)	$43.77M
Net Income	$-35.04M
Gross Margin	0.00%

Latest XLO News

Xilio Therapeutics Extends Runway to 2028, Plans XTX501 IND in Mid-2026 — May 12, 2026
Xilio Therapeutics Plans 1-for-14 Reverse Split to Cut Shares to 5.2M — Mar 12, 2026
Xilio Therapeutics Raises $40M with 74.8M Pre-Funded Warrants at $0.5349 — Feb 12, 2026

Recent XLO Insider Trades

Shannon James Samuel bought 5.00K (~$43.95K) on Mar 26, 2026.
Brennan Kevin M. sold 1.83K (~$1.17K) on Jan 2, 2026.
Frankenfield Christopher James sold 7.03K (~$4.52K) on Jan 2, 2026.

XLO Analyst Consensus

XLO analyst coverage data. Average price target: $0.00.

Common questions about XLO

What is the AI research view on XLO?: Rallies AI research for XLO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for XLO?: Rallies AI research for XLO combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is XLO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for XLO. It does not provide personalized investment advice.